摘要
【目的】探讨类风湿关节炎(rheumatoidarthritis,RA)患者血清半乳糖凝集素~3(galectin-3)水平及其在RA疾病活动性、肺间质纤维化中的作用与相关影响因素。【方法】应用酶联免疫吸附法(E1.ISA)检测50例RA患者及30例正常健康对照者血清galectim3水平,并分析其与临床相关症状及实验室有关指标的关系。【结果】RA患者血清galectin-3水平较正常对照明显升高(P〈0.05),而且与红细胞沉降率(ESR)、IgA、DA$28呈正相关关系(r=0.288,r=0.314,r=0.499,P〈0.05,P〈0.05,P〈0.05)。RA患者低疾病活动组、中疾病活动组及高疾病活动组间血清galectin-3水平比较也存在统计学差异(P〈0.05),此外,RA合并肺间质纤维化组患者血清galectin-3水平较非肺间质纤维化组显著升高(Pd0.05)。【结论】galectin-3参与了RA的发生发展,其水平的高低反映疾病的活动度,且与RA肺间质纤维化密切相关。
[Objective] To explore the serum level of galectin-3 in patients with rheumatoid arthritis(RA) and its role in the disease activity and pulmonary interstitial fibrosis of RA and the related influential factor. [Methods] Serum level of galectin-3 in 50 RA patients and 30 normal healthy controls were determined by en- zyme-linked immunosorbent assay(ELISA). The relationship of galectin-3 level with clinical symptoms and la- boratory indicators was analyzed. [Results] Compared with normal control group, serum level of galectin-3 in RA patients obviously increased( P d0.05). There was positive correlation between serum galectin-3 level and ESR, IgAand DAS28(r=0.288, r=0.314, r=0.499, Pal0.05, Pd0.05,P%0.05). There were signifi- cant differences in serum galectin-3 level in RA patients among low disease activity group, moderate disease ac- tivity group and high disease activity group( P d0.05). Moreover, serum galectin-3 level in RA patients with pulmonary interstitial fibrosis was significantly higher than that in RA patients without interstitial pulmonary fibrosis( P %0.05). [Conclusion] Galectin-3 involves in the development and progression of RA. Galectin-3 level reflects the disease activity, and is correlated with RA interstitial pulmonary fibrosis.
出处
《医学临床研究》
CAS
2013年第3期423-425,共3页
Journal of Clinical Research
基金
辽宁省科技攻关项目(No.2012225097)